tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Champions Oncology Inc

CSBR
Add to Watchlist
5.096USD
+0.086+1.72%
Close 09-09 16:00（ET）
69.43MMarket Cap
LossP/E TTM
After-hours  (ET)0.000USD0.000

Champions Oncology Inc

5.096
+0.086+1.72%
Overview
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

CSBR Financials

See Champions Oncology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
69.43M
Dividend TTM
0.00
P/E TTM
-28.90
EPS TTM
-0.17
Revenue
59.42M
Net Profit
4.70M
ROE
-48.05%
ROA
-7.93%

Champions Oncology Inc Earnings Date

Latest Release
Sep 10, 2026
EPS / Forecast
--/-0.01
Revenue / Forecast
--/15.04M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
64.01%-0.05
-106.12%-0.02
-63.72%0.02
-132.74%-0.03
-1558.66%-0.13
276.29%0.33
134.90%0.05
150.84%0.10
95.75%-0.01
-3.46%-0.19
-12903.39%-0.15
---0.19
---0.19
---0.18
--0.00
---0.02
----
----
----
----
Revenue
11.98%13.84M
-2.82%16.56M
11.46%15.04M
-0.47%13.99M
-11.76%12.36M
41.77%17.04M
16.56%13.49M
11.94%14.06M
7.12%14.00M
-5.90%12.02M
-18.96%11.57M
-8.61%12.56M
1.51%13.07M
-3.18%12.77M
21.17%14.28M
22.15%13.74M
21.90%12.88M
22.02%13.19M
16.50%11.79M
17.87%11.25M
Net Profit
63.65%-667.00K
-106.21%-279.00K
-63.19%268.00K
-133.21%-436.00K
-1583.49%-1.83M
277.67%4.50M
135.15%728.00K
151.17%1.31M
95.74%-109.00K
-3.73%-2.53M
-12843.75%-2.07M
-704.39%-2.57M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16.00K
-85.47%-319.00K
24.23%-344.00K
-17.94%787.00K
27600.00%277.00K
-329.33%-172.00K
Net Margin
67.54%-4.82%
-106.39%-1.68%
-70.79%1.58%
-135.66%-3.33%
-1807.91%-14.85%
225.32%26.38%
130.16%5.40%
145.71%9.34%
96.03%-0.78%
-10.24%-21.05%
-15872.06%-17.90%
---20.43%
---19.59%
---19.09%
---0.11%
---2.32%
----
----
----
----
Gross Margin
23.40%50.78%
-23.73%46.65%
15.06%51.70%
-13.75%42.87%
-14.67%41.15%
76.29%61.17%
4.95%44.93%
28.02%49.70%
9.94%48.22%
-12.66%34.70%
-10.58%42.82%
--38.83%
--43.86%
--39.72%
--47.88%
--48.69%
----
----
----
----
Debt to assets ratio
-53.15%0.32%
-56.18%0.37%
-59.57%0.47%
-55.39%0.60%
--0.68%
--0.84%
--1.17%
--1.34%
----
----
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
Income Statement
Revenue
11.98%13.84M
-2.82%16.56M
11.46%15.04M
-0.47%13.99M
-11.76%12.36M
41.77%17.04M
16.56%13.49M
11.94%14.06M
7.12%14.00M
-5.90%12.02M
-18.96%11.57M
-8.61%12.56M
1.51%13.07M
-3.18%12.77M
21.17%14.28M
22.15%13.74M
21.90%12.88M
22.02%13.19M
16.50%11.79M
17.87%11.25M
Operating profit
69.60%-521.00K
-104.16%-187.00K
-74.73%185.00K
-138.15%-507.00K
-1145.12%-1.71M
274.58%4.50M
137.44%732.00K
152.08%1.33M
109.57%164.00K
-4.84%-2.58M
-28028.57%-1.96M
-798.59%-2.55M
-449.36%-1.71M
-396.14%-2.46M
-97.34%7.00K
-13.60%-284.00K
27.27%-312.00K
-15.48%830.00K
3657.14%263.00K
-380.77%-250.00K
Net Profit
63.65%-667.00K
-106.21%-279.00K
-63.19%268.00K
-133.21%-436.00K
-1583.49%-1.83M
277.67%4.50M
135.15%728.00K
151.17%1.31M
95.74%-109.00K
-3.73%-2.53M
-12843.75%-2.07M
-704.39%-2.57M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16.00K
-85.47%-319.00K
24.23%-344.00K
-17.94%787.00K
27600.00%277.00K
-329.33%-172.00K
Balance Sheet
Current assets
-14.08%19.22M
2.48%20.18M
51.46%21.33M
59.46%21.01M
64.01%22.37M
49.24%19.70M
0.48%14.08M
-11.69%13.18M
-29.90%13.64M
-35.17%13.20M
-31.98%14.02M
-18.77%14.92M
-1.05%19.46M
14.22%20.36M
50.40%20.61M
45.86%18.37M
55.69%19.66M
27.60%17.82M
-8.59%13.70M
2.05%12.60M
Total current liabilities
-16.48%19.92M
4.06%20.68M
17.39%22.14M
18.44%22.70M
10.73%23.85M
-9.55%19.87M
-9.97%18.86M
-5.98%19.16M
-0.88%21.54M
5.64%21.97M
11.82%20.95M
22.64%20.38M
24.34%21.73M
34.18%20.80M
50.31%18.74M
42.34%16.62M
56.08%17.48M
35.79%15.50M
-2.27%12.46M
5.33%11.68M
Total assets
-16.56%26.99M
-7.12%28.45M
19.50%30.16M
22.51%30.55M
23.77%32.34M
14.34%30.63M
-10.79%25.24M
-16.63%24.93M
-23.84%26.13M
-25.90%26.79M
-22.19%28.29M
-13.04%29.91M
-3.02%34.31M
7.64%36.15M
24.13%36.36M
22.35%34.39M
28.22%35.38M
32.95%33.58M
13.73%29.30M
23.17%28.11M
Total liabilities
-19.78%22.92M
-4.33%24.07M
5.59%25.93M
6.90%27.01M
1.92%28.57M
-12.78%25.16M
-12.91%24.56M
-9.78%25.27M
-5.53%28.04M
-0.83%28.84M
3.71%28.20M
10.22%28.00M
12.91%29.68M
19.46%29.09M
28.11%27.19M
23.51%25.41M
30.35%26.28M
39.99%24.35M
12.50%21.23M
18.85%20.57M
Total equity
7.85%4.07M
-19.95%4.38M
521.29%4.23M
1165.66%3.54M
298.21%3.77M
365.74%5.47M
632.26%681.00K
-117.45%-332.00K
-141.05%-1.90M
-129.13%-2.06M
-98.99%93.00K
-78.82%1.90M
-49.03%4.64M
-23.52%7.06M
13.64%9.17M
19.17%8.98M
22.46%9.10M
17.40%9.24M
17.09%8.07M
36.73%7.54M
Cash Flow Statement
Net operating income
-129.09%-2.00M
-373.27%-1.34M
-513.07%-1.74M
80.06%560.00K
478.19%6.87M
153.32%490.00K
-148.05%-283.00K
107.79%311.00K
-162.43%-1.82M
-158.42%-919.00K
-82.08%589.00K
-1946.67%-3.99M
-186.93%-692.00K
-63.05%1.57M
167.59%3.29M
-190.28%-195.00K
140.20%796.00K
3053.33%4.26M
39.70%1.23M
130.21%216.00K
Net investment
5.93%-238.00K
66.67%-14.00K
-157.45%-242.00K
---46.00K
-327.93%-253.00K
66.67%-42.00K
-18.99%-94.00K
100.00%0.00
114.61%111.00K
83.29%-126.00K
86.92%-79.00K
11.41%-668.00K
-50.20%-760.00K
-86.17%-754.00K
-6.71%-604.00K
16.87%-754.00K
39.33%-506.00K
66.33%-405.00K
-11.86%-566.00K
-44.89%-907.00K
Net financing
40.63%-19.00K
---36.00K
-29.71%168.00K
62.16%-14.00K
77.93%-32.00K
--0.00
78.36%239.00K
93.73%-37.00K
-93.33%-145.00K
--0.00
55.81%134.00K
---590.00K
-568.75%-75.00K
-100.00%0.00
-28.93%86.00K
-100.00%0.00
-77.78%16.00K
221.43%68.00K
-90.22%121.00K
103.45%2.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its total revenue reached 59.42M, with a year-on-year change of 56.94M.

What are the current assets of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its current assets were 19.22M, with a year-on-year change of -14.08.

What are the total assets of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its total assets of Champions Oncology Inc were 26.99M, with a year-on-year change of -16.56.

What are the total liabilities of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its total liabilities of Champions Oncology Inc were 22.92M, with a year-on-year change of -19.78.

What is the total equity of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its total equity of Champions Oncology Inc was 4.07M, with a year-on-year change of 7.85.

What is the net operating income of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its net operating income of Champions Oncology Inc was -1.03M, with a year-on-year change of -121.23.

What is the net investment of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its net investment of Champions Oncology Inc was -540.00K, with a year-on-year change of -38.82.

What is the net financing of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its net financing of Champions Oncology Inc was 99.00K, with a year-on-year change of -41.76.

What is the Earnings Per Share (EPS) of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -0.08, with a year-on-year change of -124.68.

What is the net income of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its net income was -1.18M, with a year-on-year change of -124.99.

What is the net margin of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its net profit margin was -1.98, with a year-on-year change of -123.95.

What is the gross margin of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its gross margin was 48.00, with a year-on-year change of -4.28.

What is the debt-to-asset ratio of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its debt-to-asset ratio was 0.32, with a year-on-year change of -53.15.

What is the Return on Equity (ROE) of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its Return on Equity (ROE) was -30.48, with a year-on-year change of -106.06.

What is the Return on Assets (ROA) of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its Return on Assets (ROA) was -3.96, with a year-on-year change of -124.63.

What is the operating profit of Champions Oncology Inc?

According to Champions Oncology Inc's FY2026 earnings report, its operating profit was -1.03M, with a year-on-year change of -121.23.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy